Cormagnesin® 200

Magnesium deficiency is quite common, but difficult to detect.

Cormagnesin® 200 and Cormagnesin® 400 are, in addition to being used for treating magnesium deficiency, used for treating preeclampsia and eclampsia. Magnesium sulfate is the first choice and, according to studies, it can reduce the rate of eclampsia by half. 

Intravenous administration is reasonable, as it reaches the bloodstream immediately.

  • Application areas
    Magnesium deficiency when it causes muscle disorders and oral therapy is not possible. The therapy of preeclampsia and eclampsia.
  • Drug and composition
    1 ampoule (10 ml) contains 2.0475 g magnesiumsulfate-heptahydrate (equals 1000 mg magnesiumsulfate, equals 8.3 mMol magnesium or 16.6 mVal magnesium or 201.9 mg magnesium).

    Magnesium

    For other ingredients refer to the Direction for use.
  • Dosage and method of administration
    The dosage depends on the severity of the magnesium deficiency or the required need.

    The ampoule should be injected intravenous (i.v.). The intramuscular injection has to be applied deep. The intravenous injection has to be applied very slowly while the patient is lying (the first 3ml in 3 minutes).

    The injection of one ampoule should be repeated with a gap of one or two days.
  • Package Sizes
    • 10 ampoules à 10 ml Solution for Infusion - PZN 04652395
  • Required text
    Cormagnesin® 200 Injektionslösung. Active substance: magnesiumsulfate-heptahydrate. Therapeutic indications: magnesium deficiency when it causes muscle disorders and oral therapy is not possible. The therapy of preeclampsia and eclampsia. If you have any questions about risks and side effects, please read the patient information leaflet and ask your doctor or pharmacist. WÖRWAG Pharma GmbH & Co. KG, 71034 Böblingen
  • Downloads

Further products